Citation

Drozdowicz E, Rodzoch R, Matsumoto H, Skalski M, Wielgoś M, Radziwoń-Zaleska M. Medical Science Technology 2013; 54(1): 125-129.

Copyright

(Copyright © 2013)

DOI

10.12659/MST.889512

PMID

unavailable

Abstract

Postpartum depression (PPD) affects from 7% to 19% of childbearing women. Several risk factors for PPD have been identified, yet its cause remains unclear. The pathogenesis of PPD may be related to hormonal fluctuations, hypothalamus-pituitary-adrenal (HPA) axis dysregulation, and excessive inflammatory response. Psychometric scales such as the Edinburgh Postnatal Depression Scale (EPDS) are used to screen for PPD. However, to date there is lack of evidence supporting universal antepartum or postpartum screening. Selective Serotonin Reuptake Inhibitors (SSRI) are recommended as first-choice treatment. Psychotherapy has been found to be effective as well. PPD is a serious social issue due to its consequences, including an increased risk of suicide and infanticide. PPD is often under-diagnosed and untreated; therefore, efforts are needed to improve perinatal mental health care. This article summarizes the current evidence on the epidemiology, symptoms, diagnostics, etiology, and treatment of postpartum depression. © Med Sci Tech.

Language: en

Keywords

human; Depression; suicide; Review; Pregnancy; bipolar disorder; psychotherapy; Postpartum depression; infanticide; anxiety; inflammation; sleep deprivation; Edinburgh Postnatal Depression Scale; mental health care; serotonin uptake inhibitor; puerperal depression; puerperal psychosis; hormonal regulation; hypothalamus hypophysis adrenal system; corticotropin; gamma interferon; brain derived neurotrophic factor; Postnatal depression; interleukin 10; randomized controlled trial (topic); molecular pathology; Perinatal care